Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients

被引：0
|
作者：
Yildiz, A. [1 ]
Cavusoglu, M. [1 ]
Adin, S. [2 ]
Caliskan, Y. [1 ]
Ozkok, A. [1 ]
Tasci, H. [3 ]
Deniz, G. [2 ]
Sariyar, M. [3 ]
机构：
[1] Istanbul Sch Med, Internal Med, Nephrol, Istanbul, Turkey
[2] Immunol Expt Med & Res Ctr, Istanbul, Turkey
[3] Medicana Organ Transplant Ctr, Gen Surg, Istanbul, Turkey
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2015年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1676
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Different Effects on Transitional B Lymphocytes after Conversion to mTOR Inhibitors or Steroid Withdrawal in Renal Transplant Recipients
    Llinas Mallol, Laura
    Redondo Pachon, Dolores
    Raich Regue, Dalia
    Yelamos, Jose
    Perez Saez, Maria Jose
    Mir, Marisa
    Lopez Botet, Miguel
    Pascual Santos, Julio
    Crespo Barrio, Marta
    [J]. TRANSPLANTATION, 2018, 102 : S280 - S280
  • [22] DIFFERENT EFFECTS ON TRANSITIONAL B LYMPHOCYTES AFTER CONVERSION TO MTOR INHIBITORS OR STEROID WITHDRAWAL IN RENAL TRANSPLANT RECIPIENTS
    Llinas-Mallol, Laura
    Redondo, Dolores
    Jose Perez-Saez, Maria
    Raich-Regue, Dalia
    Mir, Marisa
    Yelamos, Jose
    Lopez-Botet, Miguel
    Pascual, Julio
    Crespo, Marta
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [23] Effects of Conversion From Calcineurin Inhibitors to Sirolimus or Everolimus on Renal Function and Possible Mechanisms in Liver Transplant Recipients
    Tsai, Kai-Fan
    Li, Lung-Chih
    Hsu, Chien-Ning
    Lin, Chih-Che
    Lin, Yu-Hung
    Cheng, Yu-Fan
    Wang, Chih-Chi
    Chen, Chao-Long
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03): : 326 - 334
  • [24] CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS BY PROTOCOL 6-18 MONTHS POST TRANSPLANTATION IN STABLE KIDNEY TRANSPLANT RECIPIENTS: A CASE SERIES
    Collins, M.
    Russ, G.
    [J]. NEPHROLOGY, 2008, 13 : A113 - A113
  • [25] Results of 4-Year Analysis of Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Patients: Single-Center Experience
    Sert, Mehmet
    Celik, Ali
    Kural, Kemal
    Ersan, Sibel
    Ataca, Pinar
    Atila, Koray
    Cavdar, Caner
    Sifil, Aykut
    Bora, Seymen
    Gulay, Huseyin
    Camsari, Taner
    [J]. RENAL FAILURE, 2011, 33 (08) : 789 - 794
  • [26] Conversion of Calcineurin Inhibitors With Mammalian Target of Rapamycin Inhibitors After Kidney Transplant
    Nikoueinejad, Hassan
    Soleimani, Alireza
    Mirshafiey, Abbas
    Amirzargar, Aliakbar
    Sarrafnejad, Abdolfattah
    Kamkar, Ideh
    Einollahi, Behzad
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (01) : 12 - 16
  • [27] Conversion From Calcineurin Inhibitors to Sirolimus in Kidney Transplant Recipients: A Retrospective Cohort Study
    Cardinal, H.
    Froidure, A.
    Dandavino, R.
    Daloze, P.
    Hebert, M. J.
    Colette, S.
    Boucher, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (08) : 3308 - 3310
  • [28] Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus
    Herrero, JI
    Quiroga, J
    Sangro, B
    Pardo, F
    Rotellar, F
    Cienfuegos, JA
    Prieto, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1877 - 1879
  • [29] Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors
    San Millan, Juan Carlos Ruiz
    Lopez-Hoyos, Marcos
    San Segundo, David
    Quintela, Estrella
    Rodrigo, Emilio
    Gomez-Alamillo, Carlos
    Romon, Inigo
    Arias, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 (08) : 847 - 856
  • [30] Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors
    Nashan, B
    [J]. TRANSPLANT INTERNATIONAL, 2004, 17 (06) : 279 - 285
12345